Literature DB >> 2160598

Genes transferred by retroviral vectors into normal and mutant myoblasts in primary cultures are expressed in myotubes.

B F Smith1, R K Hoffman, U Giger, J H Wolfe.   

Abstract

Retroviral vectors were used to transfer genes efficiently into rat and dog myoblasts in primary cultures under conditions which permitted the transduced myoblasts to differentiate into myotubes expressing the transferred genes. The transduced myotubes expressed normal markers of differentiation and were morphologically indistinguishable from uninfected myotubes. Retroviral vector-mediated gene transfer was also used to correct a genetic enzyme deficiency in mutant canine muscle cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160598      PMCID: PMC360696          DOI: 10.1128/mcb.10.6.3268-3271.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  12 in total

1.  Cloning and expression of a human muscle phosphofructokinase cDNA.

Authors:  P M Sharma; G R Reddy; S Vora; B M Babior; A McLachlan
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

2.  Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1.

Authors:  A B Lassar; M J Thayer; R W Overell; H Weintraub
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

3.  Effect of internal viral sequences on the utility of retroviral vectors.

Authors:  D Armentano; S F Yu; P W Kantoff; T von Ruden; W F Anderson; E Gilboa
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Muscle cell culture as a tool in animal growth research.

Authors:  R E Allen
Journal:  Fed Proc       Date:  1987-02

5.  Uptake of beta-glucuronidase by deficient human fibroblasts.

Authors:  D Lagunoff; D M Nicol; P Pritzi
Journal:  Lab Invest       Date:  1973-10       Impact factor: 5.662

Review 6.  Myogenesis: fusion, myosin synthesis, and the mitotic cycle.

Authors:  K Okazaki; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

7.  A monoclonal antibody to the embryonic myosin heavy chain of rat skeletal muscle.

Authors:  B Gambke; N A Rubinstein
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

8.  Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.

Authors:  J H Wolfe; E H Schuchman; L E Stramm; E A Concaugh; M E Haskins; G D Aguirre; D F Patterson; R J Desnick; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII.

Authors:  M E Haskins; R J Desnick; N DiFerrante; P F Jezyk; D F Patterson
Journal:  Pediatr Res       Date:  1984-10       Impact factor: 3.756

10.  Nucleotide sequence of rat preputial gland beta-glucuronidase cDNA and in vitro insertion of its encoded polypeptide into microsomal membranes.

Authors:  Y Nishimura; M G Rosenfeld; G Kreibich; U Gubler; D D Sabatini; M Adesnik; R Andy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more
  5 in total

Review 1.  Prospects for homologous recombination in human gene therapy.

Authors:  M A Vega
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

2.  Spin infection enables efficient gene delivery to muscle stem cells.

Authors:  Yusaku Kodaka; Yoko Asakura; Atsushi Asakura
Journal:  Biotechniques       Date:  2017-08-01       Impact factor: 1.993

3.  Adenovirus as an expression vector in muscle cells in vivo.

Authors:  B Quantin; L D Perricaudet; S Tajbakhsh; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 4.  Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?

Authors:  Jacqueline A Hawkins-Salsbury; Adarsh S Reddy; Mark S Sands
Journal:  Hum Mol Genet       Date:  2011-03-19       Impact factor: 6.150

5.  Expression of human factor IX in mice after injection of genetically modified myoblasts.

Authors:  S N Yao; K Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.